|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS11845 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-TRBF1/TRF1 |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human TRBF1 |
產(chǎn)品訂購信息：
英文名稱 Anti-TRBF1/TRF1
中文名稱 端粒體復(fù)制結(jié)合因子1抗體費(fèi)用
別 名 hTRF1 AS; NIMA interacting protein 2; NIMA-interacting protein 2; PIN 2; PIN2; t TRF1; Telomeric protein Pin2; Telomeric protein Pin2/TRF1; Telomeric repeat binding factor (NIMA interacting) 1; Telomeric repeat binding factor 1; Telomeric repeat binding protein 1; Telomeric repeat-binding factor 1; TERF 1; TERF1; TERF1_HUMAN; TRBF 1; TRBF1; TRF 1; TRF; TTAGGG repeat binding factor 1; TTAGGG repeat-binding factor 1.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 染色質(zhì)和核信號(hào) 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 50kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human TRBF1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
端粒體復(fù)制結(jié)合因子1抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 This gene encodes a telomere specific protein which is a component of the telomere nucleoprotein complex. This protein is present at telomeres throughout the cell cycle and functions as an inhibitor of telomerase, acting in cis to limit the elongation of individual chromosome ends. The protein structure contains a C-terminal Myb motif, a dimerization domain near its N-terminus and an acidic N-terminus. Two transcripts of this gene are alternatively spliced products. [provided by RefSeq].
Function : Binds the telomeric double-stranded TTAGGG repeat and negatively regulates telomere length. Involved in the regulation of the mitotic spindle. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways.
Subunit : Homodimer; can contain both isoforms. Found in a complex with POT1; TINF2 and TNKS1. Interacts with ATM, TINF2, TNKS1, TNKS2, PINX1, NEK2 and MAPRE1. Component of the shelterin complex (telosome) composed of TERF1, TERF2, TINF2, TERF2IP ACD and POT1. Interacts with RLIM (via N-terminus). Interacts with FBXO4. Interaction with TINF2 protects against interaction with FBXO4 and subsequent polyubiquitination and proteasomal degradation. Interacts with GNL3L; this interaction promotes homodimerization. Interacts with TIN2. Interactions with GNL3L and TIN2 are mutually exclusive (By similarity).
Subcellular Location : Nucleus. Cytoplasm, cytoskeleton, spindle. Chromosome, telomere. Note=Colocalizes with telomeric DNA in interphase and prophase cells. Telomeric localization decreases in metaphase, anaphase and telophase. Associates with the mitotic spindle.
Tissue Specificity : Highly expressed and ubiquitous. Isoform Pin2 predominates.
Post-translational modifications : Phosphorylated preferentially on Ser-219 in an ATM-dependent manner in response to ionizing DNA damage.
ADP-ribosylation by TNKS1 or TNKS2 diminishes its ability to bind to telomeric DNA.
Ubiquitinated by RLIM/RNF12, leading to its degradation by the proteasome. Ubiquitinated by a SCF (SKP1-CUL1-F-box protein) ubiquitin-protein ligase complex, leading to its degradation by the proteasome.
Similarity : Contains 1 HTH myb-type DNA-binding domain.
Database links : UniProtKB/Swiss-Prot: P54274.3
TRBF1端粒體復(fù)制結(jié)合因子1，在細(xì)胞周期的過程中都有該蛋白的存在，可抑制端粒酶的活性，限制染色體頂端的延長。端粒體復(fù)制結(jié)合因子1位于端粒體頂端，是端粒體核酸蛋白復(fù)合物的組成部分。
P63 protein P63 抑制基因(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-CD5 CD5抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh P450 1A2/CYP1A2 細(xì)胞色素P450 1A2抗體 規(guī)格 0.2ml
CD44 Kit Human 人 CD44 ELISA配對(duì)抗體 ELISA
TRIM29 英文名稱： D相關(guān)蛋白抗體 0.1ml
C9orf174 英文名稱： 9號(hào)染色體開放閱讀框174抗體 0.2ml
Anti-CD5 CD5抗體Multi-class antibodies規(guī)格： 0.2ml
NA ELISA Kit 大鼠去甲Multi-class antibodies規(guī)格： 48T
Anti-ASIC1/BNaC2/FITC 熒光素標(biāo)記酸敏感離子通道1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh FAM120C 構(gòu)成激活過氧化酶活化增生受體γ樣蛋白2抗體 規(guī)格 0.2ml
SDF-1a/CXCL12(Human Stromal cell derived factor 1a) ELISA Kit 人基質(zhì)細(xì)胞衍生因子1a 96T
MMP9 英文名稱： 基質(zhì)金屬蛋白酶-9抗體 0.1ml
ALDH9A1 英文名稱： γ-基醛脫氫酶抗體 0.2ml
Anti-ASIC1/BNaC2/FITC 熒光素標(biāo)記酸敏感離子通道1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Phospho-FLT3 (Tyr969) /FITC 熒光素標(biāo)記兔抗人、大、小鼠磷酸化FMS樣酪氨酸激酶3抗體IgGMulti-class antibodies規(guī)格： 0.2ml
ErbB-3/HER3(Epidermal growth factor receptor3) 表皮生長因子受體3(抗原)Multi-class antibodies規(guī)格： 0.5mg
CD57抗體 Anti-CD57 0.1ml
SODD 英文名稱： Bcl2結(jié)合抗凋亡蛋白4抗體 0.2ml
ETL 英文名稱： EGF毒素受體7跨膜結(jié)構(gòu)域蛋白1抗體 0.2ml
Rhesus antibody Rh phospho-GATA6(Tyr271) 磷酸化GATA結(jié)合蛋白6抗體 規(guī)格 0.1ml
ErbB-3/HER3(Epidermal growth factor receptor3) 表皮生長因子受體3(抗原)Multi-class antibodies規(guī)格： 0.5mg
大鼠內(nèi)脂素/內(nèi)臟脂肪素(visfatin)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人嗜酸性粒細(xì)胞陽離子蛋白(ECP)免疫試劑盒 Human eosinophil cationic protein,ECP ELISA Kit
MouseFMS-liketyrosinekinase3,Flt3ELISAKit小鼠FMS樣酪氨酸激酶3(Flt3)ELISA試劑盒規(guī)格：96T/48T
Ratβ2-glycoprotein1aibodyIgA/G/M,β2-GP1IgA/G/MELISA試劑盒大鼠β2糖蛋白1抗體IgA/G/M(β2-GP1IgA/G/M)ELISA試劑盒規(guī)格：96T/48T
HumanmajorhistocompatibilitycomplexⅢ,MHCⅢ/HLA-ⅢELISA試劑盒人主要組織相容性復(fù)合體Ⅲ類(MHCⅢ/HLA-Ⅲ)ELISA試劑盒規(guī)格：96T/48T
Humanpermeabilityglycoprotein,P-gpELISAKit人P糖蛋白/滲透性糖蛋白(P-gp)ELISA試劑盒規(guī)格：96T/48T
大鼠雌二醇(E2)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人免疫球蛋白G4(IgG4)免疫試劑盒 Human Immunoglobulin G4,IgG4 ELISA Kit
MouseTumornecrosisfactorβ,TNF-βELISAKit小鼠壞死因子β(TNF-β)ELISA試劑盒規(guī)格：96T/48T
石蠟切片組織APC蛋白表達(dá)CDK2顯色光學(xué)顯微鏡檢測試劑盒10/20次
Humanpro-opiomelanocoin,POMCELISA試劑盒人阿黑皮素原(POMC)ELISA試劑盒規(guī)格：96T/48T
Humahrombospondin1，TSP-1ELISAKit人血小板反應(yīng)蛋白/凝血酶敏感蛋白1(TSP-1)ELISA試劑盒規(guī)格：96T/48T
端粒體復(fù)制結(jié)合因子1抗體費(fèi)用 大鼠兒茶酚胺(CA)ELISA試劑盒 ，英文名： CA ELISA Kit
Ip Nixonn Ron (Prednisolone) ELISA Kit 豬潑尼松龍(Prednisolone)ELISA試劑盒
魚特定基因序列(Fish)核酸檢測試劑盒 48T
CLIAKitforLZM(HumanLysozyme)ELISAKit人溶菌酶規(guī)格：48T/96T
體液總膽汁酸酶循環(huán)比色法定量檢測試劑盒20次
ELISAKitNADPH雞煙酰胺腺嘌呤二核苷酸磷酸規(guī)格：48T/96T
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 端粒體復(fù)制結(jié)合因子1抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及*基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定：
1）端粒體復(fù)制結(jié)合因子1抗體費(fèi)用 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗(yàn)測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
|
|
|
|
|
